Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and Depression

J Alzheimers Dis. 2020;76(2):733-751. doi: 10.3233/JAD-200141.

Abstract

Background: By the time Alzheimer's disease and related disorders (ADRD) are diagnosed, efficacy of treatments is limited. Preventive interventions are urgently needed.

Objective: To design a randomized controlled trial to assess a novel intervention that aims to prevent ADRD in high-risk groups.

Methods: We report on the rationale and describe the design of a multisite randomized controlled trial that aims to prevent ADRD in older persons with: (1) mild cognitive impairment (MCI); (2) remitted major depressive disorder (MDD) without MCI; or (3) remitted MDD with MCI.

Results: PACt-MD (Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and Depression) is a trial that randomized 375 older participants with MCI, MDD, or MCI + MDD to cognitive remediation (CR) plus transcranial direct current stimulation (tDCS) or sham-CR + sham-tDCS for 5 days/week for 8 weeks followed by boosters for 5 days/week once every 6 months until participants progress to MCI or ADRD, or the end of the study. Between boosters, participants are asked to train on CR daily. At baseline, end of 8 weeks, and yearly from baseline, participants undergo clinical, cognitive, and functional assessments. The primary aims are to compare the efficacy of CR + tDCS versus sham + sham in preventing: 1) long-term cognitive decline; and 2) incidence of ADRD or MCI. The secondary aim is to assess for cognitive improvement after the 8-week course. We will also explore the moderating and mediating effects of several biomarkers collected from the participants.

Conclusion: PACt-MD is unique in combining brain stimulation and a psychosocial intervention to prevent ADRD. PACt-MD is also a platform for studying multi-domain biomarkers that will advance our understanding of the relationships among MCI, MDD, and ADRD.

Keywords: Alzheimer’s disease and related disorders; PACt-MD; cognitive remediation; major depressive disorder; mild cognitive disorder; prevention; transcranial direct current stimulation.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / prevention & control*
  • Biomarkers / metabolism
  • Cognitive Dysfunction / epidemiology
  • Cognitive Dysfunction / metabolism
  • Cognitive Dysfunction / therapy*
  • Cognitive Remediation / methods*
  • Combined Modality Therapy / methods
  • Dementia / epidemiology
  • Dementia / metabolism
  • Dementia / prevention & control
  • Depression / epidemiology
  • Depression / metabolism
  • Depression / therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Ontario / epidemiology
  • Transcranial Direct Current Stimulation / methods*

Substances

  • Biomarkers